With immunotherapy and combination therapy becoming the major focus of oncology research over the last several years, World Preclinical Congress has strengthened and expanded its cancer coverage. Translational strategies, novel preclinical models, combination therapy design, new immuno-oncology targets, cell analysis technologies, nano-delivery methods are the key topics that will be discussed at the event. Join pharmaceutical, biotech, and academic stakeholders for interactive sessions, panel discussions, and short courses, all of which are geared toward providing opportunities for active networking and collaboration. By attending you will be able to gain strategic insight into solutions for increasing the predictability of preclinical cancer studies and accelerating translation in oncology in general and immuno-oncology in particular.

June 13-14

Preclinical Models and Tools in Oncology - Part 1

Cancer Immunotherapy and Combinations

June 14-15

Tumor Models for Cancer Immunotherapy - Part 2

Immuno-Oncology Targets

June 15 - 16

SYMPOSIUM: Nano-Delivery: Nucleic Acids, Cancer Immunotherapy and Beyond

2016 Highlights

Conference At A Glance

Plenary Keynotes

Choose your language
Traditional Chinese
Simplified Chinese

Premier Sponsor

 Charles River Discovery

Mitra Biotech


Arrow Short Courses

Arrow Sponsors

Arrow Media Partners

Arrow Symposia

Arrow Posters

Download Brochure(PDF)